Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency

Clinical trial NCT00489294 · COMPLETED

Trial details

NCT number: NCT00489294
Sponsor: Phage Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Growth Hormone Deficiency

Start date: 2004-08-01
Primary completion: 2005-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.